The primary objective of this trial is to provide a rigorous assessment of the efficacy, feasibility and safety of the Vancouver 3M Clinical Pathway protocol in patients undergoing elective transfemoral TAVR with the SAPIEN XT valve.
Visit ClinicalTrials.gov for more information.
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.